---
title: "Cadrenal Therapeutics CEO presents at H.C. Wainwright Global Investment Conference"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297910480.md"
description: "Cadrenal Therapeutics CEO Quang X. Pham will present at H.C. Wainwright’s 28th Annual Global Investment Conference in New York (Sept. 14-16, 2026). He will discuss the company's cardiac acute critical care franchise and partnering plans for CAD-1005, frunexian, and tecarfarin, alongside holding one-on-one investor meetings."
datetime: "2026-09-03T12:04:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297910480.md)
  - [en](https://longbridge.com/en/news/297910480.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297910480.md)
generator: "portal-rs"
---

# Cadrenal Therapeutics CEO presents at H.C. Wainwright Global Investment Conference

-   Cadrenal Therapeutics will participate in H.C. Wainwright’s 28th Annual Global Investment Conference on Sept. 14-16, 2026, in New York. \* CEO Quang X. Pham is slated to discuss the company’s cardiac acute critical care franchise and partnering plans for CAD-1005, frunexian, tecarfarin. \* Pham is also scheduled for one-on-one investor meetings during the conference. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cadrenal Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609030800PRIMZONEFULLFEED9820809) on September 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [CVKD.US](https://longbridge.com/en/quote/CVKD.US.md)

## Related News & Research

- [Cadrenal aligns pipeline into Cardiac Acute Critical Care Franchise, shifts to partnership-driven model](https://longbridge.com/en/news/293338591.md)
- [Cadrenal Therapeutics reports Q1 results](https://longbridge.com/en/news/285574137.md)
- [New Study Links HFSA OMT-HF Education to Changes in Heart Failure Prescribing](https://longbridge.com/en/news/298592412.md)
- [Cardiac PET Alliance Launches to Protect Patient Access to the Nation's Most Advanced Non-Invasive Cardiac Imaging Technology](https://longbridge.com/en/news/298469145.md)
- [Inter Parfums announces availability of 2026 half-year report](https://longbridge.com/en/news/298413126.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**